Roger Bannister
St Mary's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Roger Bannister.
Journal of the Neurological Sciences | 1980
David J. Thomas; Roger Bannister
Cerebral blood flow (CBF) measurements have been made at systolic pressures between 40 and 170 mm Hg in 8 patients with chronic autonomic failure and widespread sympathetic efferent defects. Hypotension was produced by head up tilt. Cerebral autoregulation was preserved over a wide range and only failed at a systolic pressure close to 60 mm Hg, which is below the level at which it fails in normal subjects. Therefore, although autoregulation is probably mediated largely by local myogenic factors, its lower limit appears to be reduced by defective sympathetic function. These findings help to explain the remarkable tolerance of severe postural hypotension in autonomic failure.
The Lancet | 1967
S. Cohen; Roger Bannister
Abstract In a patient with disseminated sclerosis, lymphocytic cells of the cerebrospinal fluid maintained in vitro synthesised immunoglobulins G and A, but not IgM. This provides a direct demonstration that IgG and IgA, present in the cebrospinal fluid, were derived at least in part from cells within the central nervous system.
The Lancet | 1978
Bleddyn Davies; Roger Bannister; Peter Sever
The short-term effects of pressor amines were investigated in four patients with postural hypotension caused by autonomic failure. In supine patients p-tyramine alone or with a monoamine-oxidase inhibitor produced pronounced supine hypertension without abolishing the symptoms associated with a postural fall in blood-pressure. Phenylephrine or ephedrine maintained a normal blood-pressure on standing but caused supine hypertension. Thus the effects of p-tyramine with or without a monoamine-oxidase inhibitor were unpredictable and did not include relief of postural hypotension. Phenylephrine or ephedrine had some beneficial effect, but since all these drugs influence standing pressure only at the expense of pronounced supine hypertension, alternative therapy must be sought.
Movement Disorders#R##N#Neurology | 1981
Roger Bannister; David R. Oppenheimer
Publisher Summary This chapter discusses progressive autonomic failure that occurs as an additional feature in two distinct, well-recognized types of primary degenerative disease, namely, Parkinsons disease and multiple-system atrophy. Whatever their clinical resemblances, Parkinsons disease and striatonigral degeneration differ in their histopathology. As with Parkinsonism, autonomic failure may occur in a number of unrelated conditions. The neurological, as opposed to the cardiovascular, features are equally insidious. In progressive autonomic failure, the homeostatic control of blood pressure is disturbed by lesions at several levels from the hypothalamus to the periphery. Cardiovascular reflexes, like somatic reflexes, have afferent, central, and efferent connections, and the next stage in the investigation of postural hypotension and a blocked Valsalva manoeuvre is to try to show whether the lesion is afferent or efferent.
Journal of The Autonomic Nervous System | 1983
Roger Bannister
A discussion of progressive autonomic failure in man. This is one of the few neurological diseases disrupting cardiovascular function. Both central and peripheral pathways are involved. Means of diagnosing defects in autonomic reactions are described. Abnormalities in responses due to multiple system atrophy (MSA) are discussed most extensively.
Brain | 1972
Roger Bannister; David R. Oppenheimer
Brain | 1981
Roger Bannister; W. P. R. Gibson; Leslie Michaels; David R. Oppenheimer
Brain | 1977
Roger Bannister; Peter Sever; Maurice Gross
Brain | 1967
Roger Bannister; Leslie Ardill; Peter Fentem
QJM: An International Journal of Medicine | 1969
Roger Bannister; Leslie Ardill; Peter Fentem